Biosimilars Blog
Privacy Blog
RF EMerge Blog
RF 360


Insightful. Precise. Skilled.

Daniel Shores at Innovator Bootcamp During MassBio's State of Partnering, the Premier Life Sciences Innovation Summit


May 14, 2021

Partner Daniel Shores will speak to early-stage innovators on intellectual property (IP) strategy for emerging biopharma companies during the innovator bootcamp at MassBio's State of Partnering, taking place virtually May 10-14, 2021. Mr. Shores' session will take place on Friday, May 14.

The life sciences’ premier innovation summit, MassBio’s State of Partnering is an interactive and immersive digital experience that connects emerging companies with the partners, insights, and resources they need to take their businesses to the next level.

From May 10-12, biopharma companies Bayer, Ipsen, and Takeda will present their innovation strategy. On May 13 and 14, early-stage companies will participate in the innovator bootcamp, an intensive deep-dive into the tools and resources needed to grow a company, including Mr. Shores session on IP strategy. Additional sessions during the bootcamp include presentations by experts from KPMG, March and LcLennan, Morgan Stanley, and Bayer. 

Select early-stage companies will have the opportunity to meet one-on-one with biopharma company leaders to discuss potential partnerships.

To learn more about the event, and to register, please visit the event page.